IVIg vs prednisolone
Incidence of CAAs (acute phase) · people undergoing initial treatment for KD
It is very uncertain whether primary treatment with intravenous immunoglobulin (IVIG) changes incidence of CAAs (acute phase) compared with prednisolone (very low certainty).
1 finding from 1 review
- Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes onlyOR 0.6 [0.24, 1.48]2 studies · 140 participantsVery low